Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.

This study has been completed.
Sponsor:
Collaborators:
The Dana Foundation
Merck Sharp & Dohme Corp.
Kos Pharmaceuticals
Information provided by:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00307307
First received: March 24, 2006
Last updated: May 18, 2006
Last verified: March 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given